The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
Christoph Wießner(Novartis (Switzerland)), M. Staufenbiel(Novartis (Switzerland))
Cited by 190
Related Papers
No related papers found
Powered by citation graph analysis